- Filed
- Dec 16, 2016 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2016 · Dec 15, 2016 | 3.78B sh |
| Shares Diluted | Q3 2016 · Aug 31, 2016 | 3.78B sh |
| Shares Diluted | Q3 2016 · Aug 31, 2016 | 3.73B sh |
| Shares Diluted | Q3 2016 · Aug 31, 2015 | 3.8B sh |
| Shares Diluted | Q3 2016 · Aug 31, 2015 | 10.98B sh |
| Operating Cash Flow | Q3 2016 · Aug 31, 2016 | −$346.06K |
| Operating Cash Flow | Q3 2016 · Aug 31, 2015 | −$181.34K |
| Long Term Debt | Q3 2016 · Aug 31, 2016 | $448.65K |
| Long Term Debt | Q3 2016 · Nov 30, 2015 | $409.61K |
| Cash And Equivalents | Q3 2016 · Aug 31, 2016 | $1.43K |
| Cash And Equivalents | Q3 2016 · Nov 30, 2015 | $8.98K |
| Cash And Equivalents | Q3 2016 · Aug 31, 2015 | $5.65K |
| Cash And Equivalents | Q3 2016 · Nov 30, 2014 | $1.83K |
| Stockholders Equity | Q3 2016 · Aug 31, 2016 | −$10.4M |
| Stockholders Equity | Q3 2016 · Nov 30, 2015 | −$9.1M |
| Current Liabilities | Q3 2016 · Aug 31, 2016 | $9.92M |
| Current Liabilities | Q3 2016 · Nov 30, 2015 | $9.14M |
| Total Liabilities | Q3 2016 · Aug 31, 2016 | $10.37M |
| Total Liabilities | Q3 2016 · Nov 30, 2015 | $9.55M |
| Current Assets | Q3 2016 · Aug 31, 2016 | $68.24K |
| Current Assets | Q3 2016 · Nov 30, 2015 | $365.73K |
| Total Assets | Q3 2016 · Aug 31, 2016 | $90.77K |
| Total Assets | Q3 2016 · Nov 30, 2015 | $444.54K |
| Eps Diluted | Q3 2016 · Aug 31, 2016 | $0.00 |
| Eps Diluted | Q3 2016 · Aug 31, 2016 | $0.00 |
| Eps Diluted | Q3 2016 · Aug 31, 2015 | $0.00 |
| Eps Diluted | Q3 2016 · Aug 31, 2015 | $0.00 |
| Eps Basic | Q3 2016 · Aug 31, 2016 | $0.00 |
| Eps Basic | Q3 2016 · Aug 31, 2016 | $0.00 |
| Eps Basic | Q3 2016 · Aug 31, 2015 | $0.00 |
| Eps Basic | Q3 2016 · Aug 31, 2015 | $0.00 |
| Sga Expense | Q3 2016 · Aug 31, 2016 | $191.42K |
| Sga Expense | Q3 2016 · Aug 31, 2016 | $671.68K |
| Sga Expense | Q3 2016 · Aug 31, 2015 | $234.67K |
| Sga Expense | Q3 2016 · Aug 31, 2015 | $402.64K |
| Net Income | Q3 2016 · Aug 31, 2016 | −$456.89K |
| Net Income | Q3 2016 · Aug 31, 2016 | −$1.2M |
| Net Income restated | Q3 2016 · Aug 31, 2015 | $515.7K |
| Net Income restated | Q3 2016 · Aug 31, 2015 | $14.31K |
| Operating Income | Q3 2016 · Aug 31, 2016 | −$191.42K |
| Operating Income | Q3 2016 · Aug 31, 2016 | −$583.51K |
| Operating Income restated | Q3 2016 · Aug 31, 2015 | −$123.8K |
| Operating Income restated | Q3 2016 · Aug 31, 2015 | −$302.17K |
| Cost Of Revenue | Q3 2016 · Aug 31, 2016 | $191.21K |
| Cost Of Revenue | Q3 2016 · Aug 31, 2015 | $184.21K |
| Cost Of Revenue | Q3 2016 · Aug 31, 2015 | $184.21K |
| Revenue | Q3 2016 · Aug 31, 2016 | $279.38K |
| Revenue restated | Q3 2016 · Aug 31, 2015 | $295.08K |
| Revenue restated | Q3 2016 · Aug 31, 2015 | $296.91K |
| Capex | Q3 2016 · Aug 31, 2015 | $810 |